Search Within

Diane Lauren Reidy

  1. "Tow Center for Developmental Oncology (TCDO) "
Formats
  1. Journal Article (6)
  2. Meeting Abstract (1)
Groups
  1. Center for Pancreatic Cancer Research (7)
  2. Department of Medicine (7)
  3. Department of Pathology and Laboratory Medicine (7)
  4. Gastrointestinal Oncology Service (7)
  5. Solid Tumor Oncology Division (7)
  6. Tow Center for Developmental Oncology (TCDO) (7)

More Groups

People
  1. Michael Berger (5)
  2. Marc Ladanyi (4)
  3. David Klimstra (3)
  4. Diana Mandelker (3)
  5. Eileen O'Reilly (3)
  6. Leonard Saltz (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2019 (1)
  4. 2018 (4)
Publications
  1. Journal of Clinical Oncology (2)
  2. Clinical Colorectal Cancer (1)
  3. Endocrine Pathology (1)
  4. JCO Precision Oncology (1)
  5. Nature Genetics (1)
  6. Nature Medicine (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Nature Publishing Group (2)
  3. Elsevier Inc. (1)
  4. Springer Nature (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • TERT copy number alterations, promoter mutations and rearrangements in adrenocortical carcinomas
    Journal Article

    Gupta, S.; Won, H.; Chadalavada, K.; Nanjangud, G. J.; Chen, Y. B.; Al-Ahmadie, H. A.; Fine, S. W.; Sirintrapun, S. J.; Strong, V. E.; Raj, N.; more...
    Endocrine Pathology (2022)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Akala, O. O.; Shah, R.; Untch, B. R.; Kelly, V.; Chou, J. F.; Ladanyi, M.; Berger, M. F.; Klimstra, D. S.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability
    Journal Article

    Raj, N.; Shah, R.; Stadler, Z.; Mukherjee, S.; Chou, J.; Untch, B.; Li, J.; Kelly, V.; Osoba, M.; Saltz, L. B.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
    Journal Article

    Alvarez, M. J.; Subramaniam, P. S.; Tang, L. H.; Grunn, A.; Aburi, M.; Rieckhof, G.; Komissarova, E. V.; Hagan, E. A.; Bodei, L.; Clemons, P. A.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • Brain metastases in pancreatic ductal adenocarcinoma: Assessment of molecular genotype - Phenotype features - An entity with an increasing incidence?
    Journal Article

    Jordan, E. J.; Lowery, M. A.; Basturk, O.; Allen, P. J.; Yu, K. H.; Tabar, V.; Beal, K.; Reidy, D. L.; Yamada, Y.; Janjigian, Y.; more...
    Clinical Colorectal Cancer (2018)

    Fulltext@MSK | Save